Intraoperative predictors of major adverse cardiovascular and cerebrovascular events risk following hepatobiliary and pancreatic surgery: insights from the INSPIRE dataset

肝胆胰手术后主要不良心血管和脑血管事件风险的术中预测因素:来自 INSPIRE 数据集的启示

阅读:1

Abstract

BACKGROUND: Major adverse cardiovascular and cerebrovascular events (MACCE) pose significant challenges in hepatobiliary and pancreatic surgeries, contributing to increased morbidity, mortality, and healthcare burdens. Accurate identification of perioperative risk factors remains critical yet underexplored due to limited large-scale data. This study aimed to find intraoperative predictors of MACCE within 30 (MACCE-30) and 90 days (MACCE-90) post-surgery using the INSPIRE database. METHODS: A retrospective cohort of 6135 patients from Seoul National University Hospital was analyzed. MACCE was defined as angina, myocardial infarction, cardiac arrest, arrhythmia, heart failure, stroke, or in-hospital mortality. Variables including patient characteristics, intraoperative factors (e.g., estimated blood loss [EBL], crystalloid volume), and comorbidities were extracted. Univariate Cox proportional hazards models identified variables (p < 0.2) for multivariate analysis, with Kaplan-Meier plots visualizing survival differences. RESULTS: Of 6135 patients, 179 experienced MACCE-90. Multivariate analysis identified male sex (HR 1.88, 95% CI 1.27-2.78, p < 0.01), EBL (HR 1.19, 95% CI 1.03-1.37, p = 0.02), and crystalloid infusion volume (HR 1.29, 95% CI 1.00-1.65, p = 0.05) as significant predictors of MACCE-90. Mean EBL was 565 mL (MACCE) versus 357 mL (non-MACCE), and crystalloid volume was 498 mL versus 486 mL. We observed no significant difference in early survival based on sex, EBL, or infused crystaollioids. CONCLUSION: Male sex, higher EBL, and crystalloid volumes predict MACCE-90. Optimized management and refined protocols are needed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。